Anzeige
Mehr »
Login
Freitag, 16.04.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
Codename: Siebzehntausend! Rritual landet den "Super-Vertrag"!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QNQR ISIN: SE0015504097 Ticker-Symbol: 8LY 
Frankfurt
16.04.21
14:06 Uhr
1,030 Euro
-0,005
-0,48 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
ONCOZENGE AB Chart 1 Jahr
5-Tage-Chart
ONCOZENGE AB 5-Tage-Chart

Aktuelle News zur ONCOZENGE Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
19.03.Nasdaq Stockholm AB: Last day of trading in paid subscription shares (BTA) of OncoZenge AB (112/21)854Trading in OncoZenge AB paid subscription shares is to cease. The last trading day is March 23, 2021. Short name: ONCOZ BTA --------------------------- ISIN code: SE0015531231 --------------------------- Orderbook...
► Artikel lesen
ONCOZENGE Aktie jetzt für 0€ handeln
17.02.XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 17.02.2021704The following instruments on XETRA do have their first trading 17.02.2021 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag am 17.02.2021 Aktien 1 BMG392401094 GL Ltd. 2 SG2F48989824...
► Artikel lesen
15.02.Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of OncoZenge AB (19/21)320With effect from February 19, 2021, the subscription rights in OncoZenge AB will be traded on First North Growth Market. Trading will continue up until and including March 02, 2021. Instrument: ...
► Artikel lesen
12.02.Nasdaq Nordic: Nasdaq Stockholm Welcomes OncoZenge to the Nasdaq First North Growth Market238Stockholm, February 12, 2020 - Nasdaq (Nasdaq: NDAQ) announces that trading in OncoZenge AB's shares (short name ONCOZ) commences today on Nasdaq First North Growth Market. The company belongs to the...
► Artikel lesen
11.02.Nasdaq Stockholm AB: Listing of OncoZenge AB, on Nasdaq First North Growth Market Sweden (54/21)207On request of OncoZenge AB, company registration number 559261-9968, Nasdaq Stockholm AB has admitted the company's shares to trading on Nasdaq First North Growth Market Sweden with effect from February...
► Artikel lesen
10.02.MOBERG PHARMA: OncoZenge has been approved for listing on Nasdaq First North Growth Market1
09.02.Nasdaq Stockholm AB: Listing of OncoZenge AB, on Nasdaq First North Growth Market (49/21)267Nasdaq Stockholm AB has assessed that OncoZenge AB, company registration number 559261-9968, fulfills Nasdaq First North Growth Market's listing requirements. Provided that OncoZenge AB, applies...
► Artikel lesen
08.02.MOBERG PHARMA: OncoZenge has obtained a conditional approval for listing on Nasdaq First North Growth Market and publishes prospectus1
29.01.MOBERG PHARMA: Announcement of terms for the fully guaranteed rights issue in OncoZenge, timetable for the listing and record date for Lex Asea1
07.01.MOBERG PHARMA: OncoZenge announces issue of European Patent related to BupiZenge-
11.12.20MOBERG PHARMA: OncoZenge raises MSEK 10 ahead of spin-off and separate listing-
30.11.20Moberg Pharma obtains positive decision from the Swedish Tax Agency regarding the Lex Asea distribution of the shares in OncoZenge1
23.11.20ONCOZENGE AB: Invitation to market update in Moberg Pharma on November 25[th]1
16.11.20MOBERG PHARMA: OncoZenge secures approximately SEK 70 million in financing ahead of spin-off and separate listing2
14 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1